513060 Bosera Hang Seng Health Care ETF(QDII)
- 0.359
- +0.002+0.56%
Don't panic! Is Xiaomo shouting that they will continue to increase their positions in May?
Is the fund manager's annual salary capped at 1.2 million?
Foreign investors increased the Science and Technology Innovation Board, and the Science Innovation 100 ETF Huaxia showed resilience this week
The latest interpretation of the 2024 “Global Perspective: Betting on China” Top Ten Core ETFs (Weekly Report)
The innovative drug sector ushered in full chain policy support, and Hang Seng Healthcare ETF (513060) soared
Glonghui, March 14 | The Hong Kong stock healthcare sector rose rapidly at the end of yesterday. The Hang Seng Healthcare Index rose 2.78% after 15:00 on March 13. The index's rise and fall was reversed from -1.5% in the intraday period to a close increase of 1.42%. Opening today, Hang Seng Healthcare ETF (513060) rose more than 5.6%, up 21.6% since the bottom of February 6. Innovative drugs are the core driving force behind the rise in the index. Since this year, the innovative drug industry has continued to receive policy support from the entire top-level chain, and has successfully achieved many cases of “going overseas”, which indicates that the industry is entering a new stage of benign growth. Global innovation
The latest interpretation of the 2024 “Global Perspective: Betting on China” Top Ten Core ETFs (February Monthly Report)
The Science and Technology Innovation 100 Index rose the most in the world. The Science and Technology Innovation 100 ETF in Huaxia soared 16% in February; the artificial intelligence ETF surged 24.62% in February, the best performance
The latest interpretation of the 2024 “Global Perspective: Betting on China” Top Ten Core ETFs (January Monthly Report)
US technology stocks continued their gains. The NASDAQ ETF rose 4% in January; the dividend strategy remained resilient, and the low-dividend 100 ETF only fell slightly by 0.08% in January; the growth sector failed significantly, and the Sci-Tech Innovation 100 ETF Huaxia fell more than 20%
Interpretation of the 2024 “Global Vision, Betting on China” Top Ten Core ETFs (January 1-January 19)
Among the top ten “Global Vision, Bet on China” core ETFs in 2024, the NASDAQ ETF (159941) performed the best this week, with a cumulative increase of 2.29%
My face changed again! This 100 billion giant has a bit of a hole
Northbound funding successfully bottomed out
The latest interpretation of the top ten core ETFs that “bet on China” in 2023 (November Monthly Report)
The top ten core ETFs that “bet on China” had an average increase of 0.69% in November and a 7% decline since this year.
The scale has increased dramatically, and ETFs have become the main channel for QDII funds to “absorb money”
Gelonghui, November 10 | As domestic residents' wealth continues to accumulate, global asset allocation demand continues to increase. Coupled with the active performance of overseas markets since this year, the money-making effect is obvious. Various asset management institutions are speeding up the deployment of QDII products. Since this year, three new public funds have been added to the QDII list: Western Profit Fund, Shanghai Bank Fund, and Morgan Stanley Huaxin Fund. Additionally, many public funds, such as Ruiyuan Fund, Nord Fund, and Anxin Fund, are queuing up to apply for this qualification. According to the latest data from the State Administration of Foreign Exchange, as of October 31, a total of 22 brokerage firms or brokerage asset management subsidiaries have been approved for QDI
Net purchases of nearly 10 billion dollars! What do you smell when mainland capital is rushing to raise Hong Kong stocks on a large scale?
Mainland capital is wantonly scavenging Hong Kong stocks.
Fund October Report: Equity Index Funds Crush Over 10 Billion Fund Managers, Funding Is Crazy to Raise the Shanghai and Shenzhen 300 ETFs
Crazy shuffle
ETF rating丨Hong Kong stocks collectively weakened, Hang Seng Healthcare ETF fell 2.67%
GLONGHUI, September 21 | The three major A-share indices all closed down. At the close, the Shanghai index fell 0.77%, the Shenzhen index fell 0.9%, and the GEM index fell 0.99%. Today, the Shanghai and Shenzhen markets had a turnover of 579 billion dollars. Over 3,800 individual stocks in the two markets fell. The net sales of Beishang Capital were 4.33 billion yuan. In terms of sectors, sectors such as Starflash Concept, 6G, satellite navigation, and Huawei Hisilicon registered the highest gains, while sectors such as precious metals, pork, integrated die-casting, and diet medicine registered the highest declines. In terms of ETFs, the pharmaceutical sector had the highest growth rate, and the Taikang Public Health ETF rose 0.90%. The communications sector was strong throughout the day, and the Harvest Communications ETF rose
Capital increased its bets on science and technology online stocks last week, and the share of pharmaceutical-themed ETFs and broad-based ETFs has rarely declined
60% of ETF products closed down for the whole of last week.
ruthless person! The bearish AI boss fights back against Jedi
Is there a chance for “King of the Year” to turn around?
The latest interpretation of the top ten core ETFs to “bet on China” in 2023 (May Monthly Report)
The top ten core ETFs that “bet on China” fell 4.5% on average in May, and have fallen 2.18% since this year.
Giants take action! Hit a 33-year high
Since 2023, the shares of four ETF products have increased by more than 5 billion shares. Among them, the Huabao China Securities ETF and the E-Fangda Shanghai-Shenzhen 300 medical and health ETF have increased their holdings by more than 14.4 billion shares and 13.6 billion shares respectively.
The scale of fund issuance during the year hit a new low in nearly 5 years, and capital is sought after index funds
As of April 17, the total share of funds issued since 2023 reached 246.848 billion yuan, less than a quarter of the fund issuance scale for the same period in 2021, a new low in the past 5 years.
Internet healthcare can be included in medical insurance payments, and the Hong Kong Stock Connect Pharmaceutical ETF rose more than 4%
According to the news, on March 13, in response to the proposal to include remote diagnosis fees for Internet remote consultations in the medical insurance settlement system, the National Health Insurance Administration recently clarified that the price policies for remote consultation services provided by public medical institutions are determined by public medical institutions or provincial health insurance departments in the region where they are located in accordance with the principle of localization. If “Internet +” medical services are covered by medical insurance payments
The Drug Administration said it was speeding up the marketing of new drugs, and the Hong Kong stock of innovative drugs rose more than 3%
According to the news, yesterday, the 2023 National Drug Registration Management and Post-Marketing Drug Supervision Work Conference was held in Beijing. The conference emphasized continuing to deepen the reform of the review and approval system, speed up the marketing of clinically urgently needed new drugs, drugs for rare diseases, medicines for children, etc., innovate methods and means of supervision, and promote high-quality development of the industry.
The disclosure of the fourth quarterly report of public funds has been completed, and major data has come to light
ETFs accounted for the majority of the funds on the top 20 fund profit list in the fourth quarter, and most of them were Internet, Hang Seng Technology, and medical industry-themed ETFs. Among them, China Securities Internet ETF's profit reached 4.7 billion yuan in the fourth quarter, ranking first.